Yes, a gestational carrier can carry an embryo made from someone else’s egg via IVF and embryo transfer.
You’re asking a plain question with a lot riding on it: can one woman get pregnant using another woman’s egg? Yes, and fertility clinics do it with IVF. The person who carries the pregnancy is called a gestational carrier (or surrogate). When she didn’t provide the egg, she has no genetic tie to the baby.
Below, you’ll get the steps in order, what screening usually looks like, what affects success rates, and the paperwork that tends to come with this path.
Can A Woman Carry Another Woman’s Egg?
Yes. A clinic can create an embryo using an egg from one person and sperm from the intended parent or a donor. That embryo is placed into the uterus of the person who will carry the pregnancy.
One nuance: people say “carry an egg,” but the transfer is an embryo, not an unfertilized egg. Eggs don’t implant. Embryos can.
How Egg Source And Pregnancy Carrier Fit Together
Think of this as two roles. The egg source provides genetics. The pregnancy carrier provides the uterus and goes through pregnancy and birth. Separating those roles can make parenthood possible when the intended mother can’t carry a pregnancy, or when carrying would be risky.
Situations where this option comes up
- Uterus factor (missing uterus, scarring, severe fibroids, prior hysterectomy)
- Health conditions where pregnancy is unsafe (serious heart or kidney disease)
- Same-sex male couples using an egg donor and a carrier
- People using donor eggs due to low ovarian reserve or age-related egg issues
Plain-language terms
Gestational carrier is the pregnant person after embryo transfer. Intended parent(s) plan to raise the child. Egg donor provided the eggs used to create the embryo.
Can a woman carry another woman’s egg with IVF and embryo transfer?
The steps are straightforward on paper. Eggs are collected from the egg source, fertilized in the lab, and grown into embryos. A clinician then transfers one embryo into the carrier’s uterus. If implantation occurs, pregnancy continues with routine prenatal care.
How the medical steps usually run
- Embryo creation: eggs are retrieved after medication monitoring, then fertilized with sperm in the lab.
- Embryo storage: many clinics freeze embryos so timing is flexible for the carrier.
- Uterine prep: the carrier uses hormones so the uterine lining matches early pregnancy timing.
- Transfer day: an embryo is placed into the uterus using a thin catheter, usually without anesthesia.
- Early checks: blood testing about 9–14 days after transfer, then early ultrasound.
Medical screening and safety checks clinics commonly use
Programs tend to use layered screening: medical history, prior pregnancy history, infection testing, and general readiness for pregnancy. Many also test the carrier’s partner if there is one, since exposure risk can affect planning.
ASRM publishes guidance for clinics working with gestational carriers, including recommended evaluation and infectious disease testing around transfer. You can read the committee opinion here: ASRM recommendations for practices using gestational carriers.
What clinics often screen for
- Prior uncomplicated pregnancy and delivery history
- No uncontrolled chronic illness that raises pregnancy risk
- Up-to-date vaccinations and routine health care
- Low risk for untreated infection and substance use
- A workable plan for prenatal visits and delivery
Testing tied to egg and sperm donation
When donor eggs are involved, U.S. clinics follow federal donor eligibility rules for screening and testing communicable diseases. The FDA’s donor eligibility guidance explains the structure clinics use: FDA recommendations for determining donor eligibility.
What genetics look like in common arrangements
Genetics come from egg and sperm. Pregnancy comes from the uterus. That split lets many different family-building setups work.
Here’s a quick map of common combinations you’ll hear in clinics.
| Egg and sperm setup | Genetic link to intended parent(s) | When this setup is used |
|---|---|---|
| Intended mother’s egg + intended father’s sperm | Both intended parents (in a heterosexual couple) | Intended mother can’t carry pregnancy |
| Intended mother’s egg + donor sperm | Intended mother | Single intended mother or male-factor infertility |
| Donor egg + intended father’s sperm | Intended father | Low ovarian reserve, age-related egg issues |
| Donor egg + donor sperm | No genetic link | Embryo donation, parenting without genetic tie |
| Frozen embryo created earlier + carrier | Depends on original egg and sperm sources | Embryos exist, pregnancy is unsafe now |
| Male couple: donor egg + one partner’s sperm | One intended father | Family building for male couples |
| Reciprocal IVF: one partner’s egg + other partner as carrier | One partner (egg source) | Same-sex female couples sharing biology |
| Donor egg + donor sperm + carrier | No genetic link | When neither partner can use their gametes |
Success rates and what changes the odds
People want one clean number. Real success depends on embryo quality, lab performance, and the carrier’s uterine readiness and health. Egg age matters most, since egg quality drives embryo viability. When donor eggs are used, success rates are commonly reported per transfer rather than by intended parent age.
The CDC publishes clinic-reported ART success rates and explains how to read them when donor eggs or donor embryos are used. It’s a solid starting point for comparing clinics: CDC ART success rates.
Factors clinics watch closely
- Embryo development stage and grading
- Egg source age and health
- Single-embryo transfer versus transferring more than one embryo
- Uterine lining response during preparation
- Carrier health history, including prior pregnancy outcomes
Risks to weigh early
Even with screening, pregnancy carries medical risk. A carrier can face high blood pressure disorders, gestational diabetes, bleeding, cesarean birth, and rare emergencies. Transferring more than one embryo raises the chance of twins or higher-order multiples, which raises pregnancy risk for both carrier and babies.
Legal and consent steps that reduce conflict
Laws vary by country and by U.S. state, so the right process depends on where the carrier gives birth and where intended parents live. Most structured programs still use the same building blocks: written consent, a contract signed before medical steps begin, and a plan for parentage paperwork after birth.
In the UK, the HFEA explains the difference between gestational and traditional surrogacy and points people toward licensed treatment. Their overview gives a clear baseline: HFEA surrogacy overview.
Topics contracts often include
- Medical decision boundaries during pregnancy and delivery
- How many embryo transfers are planned
- Expenses, reimbursements, and lost wages (where allowed)
- Contact expectations during pregnancy and after birth
- Plans for prenatal testing and how results are handled
Costs and timing: what surprises people
Costs can include medical care, medications, agency fees, legal work, carrier compensation where legal, travel, and insurance gaps. Timing can stretch even when embryos are ready, since matching and screening can take months.
A common timeline looks like this: match and screening, contract signing, uterine prep, transfer, pregnancy care, birth, then parentage steps.
| Phase | Typical time window | What’s happening |
|---|---|---|
| Match and intake | Weeks to months | Match, records review, baseline screening |
| Screening and clearance | 2–6 weeks | Labs, imaging, infection testing |
| Legal agreements | 2–8 weeks | Contracts finalized before meds start |
| Uterine prep | 3–5 weeks | Hormone cycle and monitoring visits |
| Transfer and early testing | 2–3 weeks | Transfer, blood test, early ultrasound |
| Pregnancy and delivery | About 9 months | Prenatal care, scans, delivery plan |
| Parentage steps | Varies | Birth certificate and court steps where needed |
Choosing a clinic and program without getting blindsided
Start with transparency. Ask how outcomes are reported, how many gestational carrier cycles the clinic handles, and how transfer decisions are made. If you’re using donor eggs, ask about donor screening standards and the lab’s thaw and culture performance for frozen embryos.
Questions to ask on the first call
- Do you run gestational carrier cycles in-house, or coordinate with another program?
- What screening do you require for the carrier and any partner?
- Do you prefer frozen embryo transfer for carrier cycles, and why?
- What are your single-embryo transfer policies for carriers?
- How do you handle insurance gaps for prenatal care and delivery?
- What is your process if the first transfer fails?
Red flags that should slow you down
- Pressure to transfer multiple embryos as a default
- Vague answers about screening or legal steps
- No clear plan for medical records sharing and privacy preferences
- Promises of guaranteed pregnancy or guaranteed live birth
A practical checklist before you begin
These steps keep the process steady. You don’t need every item finished on day one, but you should see a clear path for each before transfer.
Medical and lab steps
- Confirm who provides eggs and sperm, and what donor screening steps apply
- Get a written summary of embryo inventory: number frozen, day of development, grading, any testing done
- Confirm the carrier’s clearance timeline and which records the clinic needs
- Ask who manages medications, monitoring, and transfer-day logistics
Legal and practical steps
- Use attorneys who handle gestational carrier contracts in the birth location
- Confirm how parentage will be handled after birth and what documents the hospital needs
- Map insurance for prenatal care, delivery, and newborn coverage
- Write down how pregnancy updates will be shared and who can be in the delivery room
When these pieces line up, the process feels less mysterious. You’re setting up clear expectations before medical steps begin.
References & Sources
- American Society for Reproductive Medicine (ASRM).“Recommendations for practices using gestational carriers: a committee opinion (2022).”Clinical guidance on screening, testing, and program practices for gestational carrier arrangements.
- Centers for Disease Control and Prevention (CDC).“ART Success Rates.”Clinic-reported assisted reproductive technology success-rate reporting and comparison tools.
- U.S. Food and Drug Administration (FDA).“Recommendations for Determining Eligibility of Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products.”Explains federal donor eligibility screening and testing expectations used for donated human tissue, including reproductive tissue.
- Human Fertilisation and Embryology Authority (HFEA).“Surrogacy.”UK regulator overview of gestational surrogacy versus traditional surrogacy and treatment at licensed clinics.
